Orally Administered Paracetamol Does Not Act Locally in the Rat Formalin Test
- 1 October 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 99 (4) , 976-981
- https://doi.org/10.1097/00000542-200310000-00034
Abstract
Background: The mechanism of action of paracetamol (acetaminophen) remains elusive because it is still under discussion as to whether it acts locally and/or centrally. The primary aim of this study was to clarify its site(s) of action (central and/or local) using the rat formalin test. Methods: Spontaneous biting and licking of the injected paw following intraplantar injection of formalin 2.5% was monitored during the two phases of nociceptive behavior (0-5 and 20-40 min after injection), and the authors examined the antinociceptive activity of paracetamol following oral, intravenous, intraplantar, and intrathecal administrations as well as the reversion of this effect by an intrathecal injection of WAY 100,635, a selective 5-HT1A receptor antagonist. Results: The oral administration of paracetamol (300, 400 mg/kg) reduced nociceptive behavior in both phases (400 mg/kg: 36.9 +/- 4.6% and 61.5 +/- 5.2% of inhibition in phases I and II, respectively, P <0.05), whereas lower doses reduced primarily the score of the second phase of the test. Only high doses of 10 to 20 mg/kg intraplantarly administered paracetamol, which were ineffective when administered subcutaneously, produced a significant but limited reduction in the early phase of the test and had no effect on the second phase or any antiinflammatory activity. Thus, this local effect did not seem to participate in the antinociceptive action of 400 mg/kg orally given paracetamol, which was totally blocked in both phases by an intrathecal injection of 40 microg WAY 100,635 per rat. Such an inhibition was not observed when paracetamol (200 microg per rat) was intrathecally coinjected with WAY 100,635, whereas the antinociceptive action of 5-HT (50 microg per rat, intrathecally) during both phases of pain was inhibited by WAY 100,635 (intrathecally). Conclusions: Orally administered paracetamol does not seem to exert any relevant local action in the formalin model of tonic pain in rats, but it might activate the serotonergic bulbospinal pathways via a supraspinal site of action that remains to be elucidated.Keywords
This publication has 43 references indexed in Scilit:
- Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H 2 synthasesProceedings of the National Academy of Sciences, 2002
- Mechanism of Acetaminophen Inhibition of Cyclooxygenase IsoformsArchives of Biochemistry and Biophysics, 2001
- Effects of caffeine and paracetamol alone or in combination with acetylsalicylic acid on prostaglandin E2 synthesis in rat microglial cellsNeuropharmacology, 2000
- Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysisProceedings of the National Academy of Sciences, 1999
- Inflammatory molecule release by β-amyloid-treated T98G astrocytoma cells: role of prostaglandins and modulation by paracetamolEuropean Journal of Pharmacology, 1998
- Cyclooxygenase-1 and Cyclooxygenase-2 Selectivity of Widely Used Nonsteroidal Anti-Inflammatory DrugsThe American Journal of Medicine, 1998
- Chronic treatments with aspirin or acetaminophen reduce both the development of polyarthritis and Fos-like immunoreactivity in rat lumbar spinal cordPain, 1994
- The effect of capsaicin and conventional analgesics in two models of monoarthritis in the ratInflammation Research, 1993
- Effect of centrally administered prostaglandin D2 and some prostaglandin synthesis inhibitors on carrageenan-induced paw oedema in ratsJournal of Pharmacy and Pharmacology, 1989
- Modification of anti-inflammatory drug effectiveness by ambient lipid peroxidesBiochemical Pharmacology, 1982